 |
市場調査レポート
商品コード
1259948
アレルギー診断の世界市場：市場規模、シェア、成長分析、製品・サービス別（消耗品、機器）、アレルゲン別、検査タイプ別（生体内検査）、エンドユーザー別－業界予測（2022年～2028年）Global Allergy Diagnostics Market Size, Share, Growth Analysis, By Product & Service(Consumables, Instruments, By Allergen, By Test Type(In Vivo Tests, By End User - Industry Forecast 2022-2028 |
||||||
| アレルギー診断の世界市場：市場規模、シェア、成長分析、製品・サービス別（消耗品、機器）、アレルゲン別、検査タイプ別（生体内検査）、エンドユーザー別－業界予測（2022年～2028年） |
|
出版日: 2022年10月23日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のアレルギー診断の市場規模は、2021年の48億米ドルから、2028年には100億3,000万米ドルになると予測されており、2022年から2028年までの予測期間中のCAGRは11.10%となっています。アレルギー、職業曝露、屋内外の大気汚染への曝露の増加、自動車による大気汚染は、市場の成長を促進しています。
当レポートでは、世界のアレルギー診断市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。
目次
エグゼクティブサマリー
親市場分析
市場概要
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- SWOT分析
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- SWOT分析
- ポーター分析
- 競争企業間の敵対関係
- 代替品の脅威
- 買い手の交渉力
- 新規参入業者の脅威
- 供給企業の交渉力
- 政治的影響
- 経済的影響
- 社会的影響
- 技術的影響
- 環境的影響
- 法的影響
世界のアレルギー診断市場：製品・サービス別
- 市場概要
- 消耗品
- 機器
- イムノアッセイアナライザー
- ELISAアナライザー
- ルミノメーター
- その他の機器
- サービス
世界のアレルギー診断市場：アレルゲン別
- 市場概要
- 吸入アレルゲン
- 食物アレルゲン
- 薬剤アレルゲン
- その他のアレルゲン
世界のアレルギー診断市場：検査タイプ別
- 市場概要
- 生体内検査
- 皮膚プリック試験
- パッチテスト
- その他の生体内試験
- 生体外試験
世界のアレルギー診断市場：エンドユーザー別
- 市場概要
- 診断検査室
- 病院ベースの検査室
- 学術・研究機関
- その他のエンドユーザー
世界のアレルギー診断市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 主要5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要な市場参入企業が採用した戦略
- 主要成功戦略
- 開発別
- 企業別
- 年別
- 市場における最近の活動
- 主要企業の市場シェア（%）（2021年）
主な企業プロファイル
- Thermo Fisher Scientific Inc.（米国）
- Siemens Healthineers（ドイツ）
- Danaher（米国）
- Omega Diagnostics Group PLC（英国）
- BioMerieux SA（フランス）
- Romer Labs Division Holding（オーストリア）
- EUROIMMUN Medizinische Labordiagnostika AG（ドイツ）
- HollisterStier Allergy（米国）
- NEOGEN Corporation（米国）
- Minaris Medical America, Inc.（米国）
- Stallergenes Greer（英国）
- HOB Biotech Group Corp., Ltd.（中国）
- HYCOR Biomedical（米国）
- R-Biopharm AG（ドイツ）
- AESKU.GROUP GmbH（ドイツ）
- ACON Laboratories, Inc.（米国）
Global Allergy Diagnostics Market was valued at USD 4.80 billion in 2021, and the market size is estimated to reach USD 10.03 billion by 2028, at a CAGR of 11.10% over the forecast period (2022-2028).
The market for allergy diagnostics is anticipated to grow as pollution levels rise. Exposure to allergens, occupational exposure, and exposure to indoor and outdoor air pollution are the key risk factors for chronic respiratory infections. City inhabitants are more likely to have allergy disorders than rural dwellers are because they are exposed to more pollution. The market for allergy diagnostics is anticipated to develop as food allergies become more prevalent.
A type of allergic illness known as food allergy is more prevalent in urban and first-world nations than in rural areas and third-world nations. The hygiene standards and the likelihood of contracting infectious diseases are two of the most obvious disparities between these areas. The development of the immune system is probably influenced by early exposure to bacterial, viral, and parasite illnesses as well as to a number of common human body microorganisms. The incidence of sensitive skin and its propensity for irritation have increased as a result of climate change, air pollution, the complexity of materials, and cosmetic goods. These elements are anticipated to fuel the allergy diagnostics market's expansion in the near future.
Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Allergy Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
The global Allergy Diagnostics market is segmented based on product & service, allergen, test type, end user, and region. Based on product & service, the Allergy Diagnostics market is segmented into Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments), Services. Based on allergen, the Allergy Diagnostics market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens. Based on test type, the Allergy Diagnostics market is segmented into In Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests. Based on end user, the Allergy Diagnostics market is segmented into Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users. Based on region, the Allergy Diagnostics market is categorized into North America, Europe, Asia-Pacific, and MEA.
Driver
Allergies, occupational exposure, and exposure to indoor and outdoor air pollution are the key risk factors for chronic respiratory illnesses. Due to greater exposure to environmental toxins in cities, there are more people with allergy problems in urban areas than in rural areas (as a result of vehicular pollution and industrial activities). More than 80% of people who live in urban areas, according to the WHO, are exposed to air quality levels that exceed WHO safety recommendations; while this is a global trend, the effects are more severe in urban areas of low-income nations. Since that air pollution from automobiles has been identified as a major risk factor for allergic disorders, this is an important indicator for the development of the market for allergy diagnostics.
Restraint
Industry participants regularly update a number of allergy diagnostic equipment, including luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers. These instruments are more expensive because they have numerous features and functionality (the price of each instrument varies based on its accuracy, flexibility, and TAT). For instance, the price of an immunoassay analyzer ranges from $10,000 to $20,000, whereas the price of a luminometer is between $3,000 and $14,000. Fully automated analyzers start at around USD 14,000 while semi-automatic ELISA readers cost between USD 2,000 and USD 5,000. In addition, there are expenses related to running this equipment such as maintenance and insurance, laboratory supervision, and overheads (such as utilities, space, and administration).
Market Trends
Reagent leasing contracts are becoming more popular as a way to lower the high cost of allergy diagnosis. Reagent rental contracts are sales agreements between manufacturers of allergy diagnostic products and end users (such as hospitals and diagnostic laboratories). By entering into a reagent-purchase contract with the producer, the end user leases or purchases instruments at a discounted price under these arrangements. By reducing the end user's initial capital investment and guaranteeing the manufacturer long-term orders, this agreement benefits both parties. In some cases, end users can rent analyzers on a per-test basis. Labs can significantly reduce costs by using cost-per-test contracts and reagent leasing agreements. Also, they help laboratories avoid significant fixed capital expenditures related to the purchase of new equipment. High-volume laboratories incur much higher expenditures than standard laboratories. The average contract lasts between five and ten years, so laboratories may stay current on the most recent developments in allergy diagnosis. Some contracts include service/maintenance fees as part of the total price, giving laboratories an additional savings.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Allergy Diagnostics Market by Product & Service
- Market Overview
- Consumables
- Instruments (Immunoassay Analyzers
- ELISA Analyzers
- Luminometers
- Other Instruments)
- Services
- Global Allergy Diagnostics Market by Allergen
- Market Overview
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other Allergens
- Global Allergy Diagnostics Market by Test Type
- Market Overview
- In Vivo Tests (Skin Prick Tests
- Patch Tests
- Other In Vivo Tests)
- In Vitro Tests
- Global Allergy Diagnostics Market by End User
- Market Overview
- Diagnostic Laboratories
- Hospital-based Laboratories
- Academic Research Institutes
- Other End Users
- Global Allergy Diagnostics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Thermo Fisher Scientific Inc., (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Omega Diagnostics Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Romer Labs Division Holding (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HollisterStier Allergy (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NEOGEN Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Minaris Medical America, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stallergenes Greer (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HOB Biotech Group Corp., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HYCOR Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- R-Biopharm AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AESKU.GROUP GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ACON Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
